Prophylactic vaccination against human papillomavirus infection and disease in women: a systematic review of randomized controlled trials
- Success for Cervical Cancer Vaccine. Grose, Simon // Australasian Science;Aug2007, Vol. 28 Issue 7, p39
The article discusses the findings of clinical trials of Gardasil vaccine from Merck to protect young women against infection by four strains of human papillomavirus (HPV) linked to cervical cancer. A study found that there are possible linkages between cancers of the upper throat and HPV...
- Changeover to added protection cervical cancer jab. // Community Practitioner;Jan2012, Vol. 85 Issue 1, p8
The article focuses on the effectiveness of Gardasil in treating cervical cancer, sexually transmitted disease, and genital warts.
- Clinical Indications for Human Papillomavirus Vaccination. Herzog, Thomas J.; Vallerie, Amy; Smith, Jennifer S.; Wright, Jason D. // Clinical Ovarian Cancer;Jun2008, Vol. 1 Issue 1, p36
With the approval of a vaccine to prevent human papillomavirus (HPV) infection and the pending approval of a second vaccine, an exciting era has dawned that provides clinicians the opportunity to prevent a majority of lower genital tract cancers. Herein, we describe the quadrivalent and bivalent...
- Quadrivalent Human Papillomavirus (HPV) Types 6, 11, 16, 18 Vaccine for the Prevention of Genital Warts in Males. Garnock-Jones, Karly; Giuliano, Anna // Drugs in R&D;2012, Vol. 12 Issue 4, p235
The article presents a discussion of the efficacy of human papillomavirus (HPV) vaccine for the prevention of genital warts caused by HPV types 6, 11, 16, and 18 in male, adapted from an article published in the 2011 issue of the journal "Drugs in R&D."
- HPV vaccine given to males prevents genital warts. // Contemporary Pediatrics;Mar2011, Vol. 28 Issue 3, p10
No abstract available.
- Expansion of cervical cancer protection through HPV vaccine in BC. Naus, Monika // British Columbia Medical Journal;Sep2012, Vol. 54 Issue 7, p346
The article deals with the recommendation of the National Advisory Committee on Immunization to use the human papillomavirus (HPV) vaccine to prevent genital warts aside from using the vaccine for cervical cancer protection. A list of the providers that will deliver the expanded program is...
- What to Do About HPV? Kotz, Deborah // U.S. News & World Report;10/29/2007, Vol. 143 Issue 15, p53
The article discusses the debate over inoculating young girls with the human papillomavirus (HPV) vaccine. The vaccine protects against four types of HPV, two of which cause genital warts and two of which are responsible for up to 70 percent of cervical cancers. The concern over giving the...
- Quantifying the Decisional Satisfaction to Accept or Reject the Human Papillomavirus (HPV) Vaccine: A Preference for Cervical Cancer Prevention. Harper, Diane M.; Irons, Billy B.; Alexander, Natalie M.; Comes, Johanna C.; Smith, Melissa S.; Heutinck, Melinda A.; Handley, Sandra M.; Ahern, Debra A. // PLoS ONE;Feb2014, Vol. 9 Issue 2, p1
Objective: Only a portion of the US population is willing to consider HPV vaccination to date. The primary aim of this study is to determine the decisional satisfaction associated with HPV vaccination. Study Design: This is a prospective survey conducted at an urban college where women...
- Cost-effectiveness of a tetravalent human papillomavirus vaccine in Germany. Hillemanns, Peter; Petry, Karl; Largeron, Nathalie; McAllister, Ruth; Tolley, Keith; Büsch, Katharina // Journal of Public Health (09431853);Apr2009, Vol. 17 Issue 2, p77
Clinical trials have demonstrated the efficacy of the tetravalent human papillomavirus (HPV) vaccination in the prevention of cervical cancer and genital warts associated with HPV types 6, 11, 16 and 18. We used an empirically calibrated Markov cohort model of the natural history of HPV to...